StockData

Design Therapeutics vs Sionna Therapeutics

DSGN and SION side by side, both in drugs. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.

How DSGN and SION compare

Design Therapeutics is the larger company, worth 4.4 times as much as Sionna Therapeutics ($621M against $141M).

Key numbers

A dot marks the better figure where higher or lower is clearly better.

MetricDSGNSION
Size and price
Market cap$621M$141M
Share price$9.92$3.12
Change, 1 year40.5%−91.3%
Change, 5 years−44.2%–
Beta (5Y)1.901.88
Employees5459
StockData Score
Total score77
Valuation score01 (better)
Growth score00
Performance score11
Health score6 (better)5
Dividend score00
Valuation
P/B3.1×0.6× (better)
FCF yield−8.9% (better)−56.4%
Profitability
Return on equity−34.1% (better)−39.0%
Financial health
Debt / equity0.000.00
Current ratio18.86 (better)13.92
Altman Z-score25.79 (better)1.34
Piotroski F-score24 (better)
Dividends and buybacks
Shareholder yield0.00%0.00%
Ownership
Held by institutions69.2%107%
Held by insiders21.2%50.1%
Insider net buying, 12 months–−$135M
Superinvestors holding–1
Short interest, % of float12.8%18.7%

Go deeper

For information only, not investment advice. Check the source filings before relying on any figure.